Latest News by Industry
IMPEL PHARMACEUTICALS INC [IMPL] has reported fiscal Q1 loss of $30.10 million.
On a per-share basis, the DE based company said its diluted earnings are $1.27 .
The Pharmaceutical Preparations firm posted revenue of $4.40 million in this period.